BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed GLUE catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:4167f98f6da76abe516a@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:GLUE P1/P2 readout (est.): Study of Oral MRT-2359 in Selected Cance
 r Patients
DESCRIPTION:Study of Oral MRT-2359 in Selected Cancer Patients\nNCT05546268
  | PHASE1/PHASE2 | ACTIVE_NOT_RECRUITING | sponsor: Monte Rosa Therapeutic
 s\, Inc\nPrimary completion date (ESTIMATED)\; top-line results usually fo
 llow later.\nDate precision: month (shown on the first day)\nTicker GLUE (
 confidence 0.9)\nSource: https://clinicaltrials.gov/study/NCT05546268\nSch
 eduling/reference data from public records\; dates can move. Not investmen
 t\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT05546268
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
